Foghorn Therapeutics
![Novel BRG1BRM Inhibitor in Metastatic Uveal Melanoma Shows Safety and Preliminary Efficacy | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Novel-BRG1BRM-Inhibitor-in-Metastatic-Uveal-Melanoma-Shows-Safety-and-Preliminary-Efficacy.jpg)
Novel BRG1/BRM Inhibitor in Metastatic Uveal Melanoma Shows Safety and Preliminary Efficacy
SG Tylor
Source – Foghorn Therapeutics Foghorn Therapeutics has highlighted the safety and tolerability of FHD-286 in metastatic uveal melanoma (mUM) through ...